Cdc5L activators encompass a range of chemical agents that are developed to modulate the activity of the Cdc5L protein, a core component of the spliceosomal complex involved in pre-mRNA splicing-a critical step in gene expression where introns are removed and exons are joined to form a continuous coding sequence. Cdc5L is a member of the pre-mRNA splicing factor family and plays a pivotal role not only in splicing but also in the regulation of various aspects of cell cycle progression and DNA damage repair pathways.
Activators targeting Cdc5L may operate through direct interactions, binding to the protein and inducing allosteric changes that enhance its splicing activity or its interaction with other components of the spliceosome. By doing so, they can facilitate the assembly of the spliceosomal complex or increase the efficiency of the splicing process itself. Direct activators might mimic endogenous ligands or bind to unique regions of Cdc5L, thereby promoting its function in the splicing machinery. On the other hand, indirect activators of Cdc5L might work by influencing cellular signaling pathways that regulate the expression levels, localization, or post-translational modifications of the protein. These modifications can include phosphorylation, ubiquitination, or sumoylation, all of which can have profound effects on Cdc5L's activity and its interactions with other cellular components. Through these pathways, indirect activators can lead to enhanced Cdc5L-mediated splicing activity by promoting a favorable cellular context for its function. Research into Cdc5L activators is of significant interest in the field of molecular biology, particularly with respect to understanding the regulation of gene expression at the post-transcriptional level. Splicing is not only fundamental to the production of mature mRNA but also contributes to the diversity of the proteome through alternative splicing events that lead to the generation of different protein isoforms from a single gene.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Uridine-5′-triphosphate, Trisodium Salt | 19817-92-6 | sc-301964 sc-301964A | 50 mg 1 g | $86.00 $118.00 | 2 | |
UTP acts as an agonist for P2Y receptors, leading to the activation of phospholipase C and elevation of intracellular calcium levels, which can activate calcium-dependent signaling pathways involved in the phosphorylation and activation of Cdc5L. | ||||||
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $38.00 $74.00 | 9 | |
ATP, as a P2 receptor agonist, can lead to the activation of phospholipase C and increase in intracellular calcium levels, which can activate calcium-dependent signaling pathways involved in the phosphorylation and activation of Cdc5L. |